PRTO stock forecast
Our latest prediction for Proteon Therapeutics, Inc.'s stock price was made on the Nov. 14, 2017 when the stock price was at 1.70$.
In the short term (2weeks), PRTO's stock price should outperform the market by 3.74%. During that period the price should oscillate between -10.17% and +19.60%.
In the medium term (3months), PRTO's stock price should outperform the market by 11.20%. During that period the price should oscillate between -20.53% and +55.64%.Get email alerts
Create a solid portfolio with PRTO
About Proteon Therapeutics, Inc.
Proteon Therapeutics, Inc. engages in the research and development of biopharmaceutical products. It produces and commercializes vonapanitase for the treatment of renal and vascular disease. The company was founded by F. Nicholas Franano and William P. Whitaker in 2001 and is headquartered in Waltham, MA.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -1.18$ per share.
The book value per share is 0.23$
Three months stock forecastNov. 14, 2017
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|